219 related articles for article (PubMed ID: 12817750)
21. TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF.
Sells Galvin RJ; Gatlin CL; Horn JW; Fuson TR
Biochem Biophys Res Commun; 1999 Nov; 265(1):233-9. PubMed ID: 10548519
[TBL] [Abstract][Full Text] [Related]
22. Treg cells suppress osteoclast formation: a new link between the immune system and bone.
Zaiss MM; Axmann R; Zwerina J; Polzer K; Gückel E; Skapenko A; Schulze-Koops H; Horwood N; Cope A; Schett G
Arthritis Rheum; 2007 Dec; 56(12):4104-12. PubMed ID: 18050211
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
24. Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha.
Ma T; Miyanishi K; Suen A; Epstein NJ; Tomita T; Smith RL; Goodman SB
Cytokine; 2004 May; 26(3):138-44. PubMed ID: 15135808
[TBL] [Abstract][Full Text] [Related]
25. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.
Horwood NJ; Udagawa N; Elliott J; Grail D; Okamura H; Kurimoto M; Dunn AR; Martin T; Gillespie MT
J Clin Invest; 1998 Feb; 101(3):595-603. PubMed ID: 9449693
[TBL] [Abstract][Full Text] [Related]
27. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
Kondo H; Guo J; Bringhurst FR
J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
[TBL] [Abstract][Full Text] [Related]
28. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
Gorny G; Shaw A; Oursler MJ
Exp Cell Res; 2004 Mar; 294(1):149-58. PubMed ID: 14980510
[TBL] [Abstract][Full Text] [Related]
29. IL-4 inhibits TNF-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo.
Fujii T; Kitaura H; Kimura K; Hakami ZW; Takano-Yamamoto T
Bone; 2012 Oct; 51(4):771-80. PubMed ID: 22776139
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
Nagata N; Kitaura H; Yoshida N; Nakayama K
Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis.
Lee SK; Kalinowski JF; Jastrzebski SL; Puddington L; Lorenzo JA
Endocrinology; 2003 Aug; 144(8):3524-31. PubMed ID: 12865334
[TBL] [Abstract][Full Text] [Related]
32. IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo.
Morita Y; Kitaura H; Yoshimatsu M; Fujimura Y; Kohara H; Eguchi T; Yoshida N
Calcif Tissue Int; 2010 Mar; 86(3):242-8. PubMed ID: 20111957
[TBL] [Abstract][Full Text] [Related]
33. Cross-talk between RANKL and FRP-1/CD98 Systems: RANKL-mediated osteoclastogenesis is suppressed by an inhibitory anti-CD98 heavy chain mAb and CD98-mediated osteoclastogenesis is suppressed by osteoclastogenesis inhibitory factor.
Mori K; Miyamoto N; Higuchi Y; Nanba K; Ito M; Tsurudome M; Nishio M; Kawano M; Uchida A; Ito Y
Cell Immunol; 2001 Feb; 207(2):118-26. PubMed ID: 11243701
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
[TBL] [Abstract][Full Text] [Related]
35. Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor.
Ono K; Kaneko H; Choudhary S; Pilbeam CC; Lorenzo JA; Akatsu T; Kugai N; Raisz LG
J Bone Miner Res; 2005 Jan; 20(1):23-9. PubMed ID: 15619666
[TBL] [Abstract][Full Text] [Related]
36. Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis.
Grcević D; Lee SK; Marusić A; Lorenzo JA
J Immunol; 2000 Oct; 165(8):4231-8. PubMed ID: 11035056
[TBL] [Abstract][Full Text] [Related]
37. Osteoclastogenesis-related antigen, a novel molecule on mouse stromal cells, regulates osteoclastogenesis.
Arai S; Amizuka N; Azuma Y; Takeshita S; Kudo A
J Bone Miner Res; 2003 Apr; 18(4):686-95. PubMed ID: 12674329
[TBL] [Abstract][Full Text] [Related]
38. Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank.
Kapur RP; Yao Z; Iida MH; Clarke CM; Doggett B; Xing L; Boyce BF
J Bone Miner Res; 2004 Oct; 19(10):1689-97. PubMed ID: 15355564
[TBL] [Abstract][Full Text] [Related]
39. CD137L- and RANKL-mediated reverse signals inhibit osteoclastogenesis and T lymphocyte proliferation.
Senthilkumar R; Lee HW
Immunobiology; 2009; 214(2):153-61. PubMed ID: 19167994
[TBL] [Abstract][Full Text] [Related]
40. T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients.
Brunetti G; Colucci S; Pignataro P; Coricciati M; Mori G; Cirulli N; Zallone A; Grassi FR; Grano M
J Periodontol; 2005 Oct; 76(10):1675-80. PubMed ID: 16253089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]